Sarkaria Jann

42PUBLICATIONS
330CO-AUTHORS
Molecular targetsGene and molecular therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Sep 06, 2026
Uncovering the signaling networks of disseminated glioblastoma cells in vivo with INSIGHT.

|Sep 04, 2026
In vivo selection of anti-glioblastoma DNA aptamer-drug conjugates in an orthotopic patient-derived xenograft model.

|Aug 21, 2026
NF1 Leucine Rich Domain-Derived Extracellular Vesicles Remodel the Glioblastoma Immune Microenvironment via an ADAM17-Associated Inflammatory Program.

|Jul 28, 2026
Divergent Roles of Canonical and Non-Canonical Mismatch Repair in Regulating Temozolomide Sensitivity in Glioblastoma.

|Jul 14, 2026
Glioblastoma Subtypes Exhibit Distinct Migration Mechanics and Immune Responses.

|Jul 08, 2026
EGFR inhibition down-regulates MGMT and enhances responsiveness to temozolomide in glioblastoma.

Pageof 7

Frequent Collaborators

10 joint publications

Paul A Decker

9 joint publications

Danielle M Burgenske

7 joint publications

Jeanette E Eckel-Passow

7 joint publications

Shiv K Gupta